Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 1
2010 3
2011 2
2012 1
2014 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
Profiling the cancer genome.
Cowin PA, Anglesio M, Etemadmoghadam D, Bowtell DD. Cowin PA, et al. Annu Rev Genomics Hum Genet. 2010;11:133-59. doi: 10.1146/annurev-genom-082509-141536. Annu Rev Genomics Hum Genet. 2010. PMID: 20590430 Review.
Inferring copy number and genotype in tumour exome data.
Amarasinghe KC, Li J, Hunter SM, Ryland GL, Cowin PA, Campbell IG, Halgamuge SK. Amarasinghe KC, et al. Among authors: cowin pa. BMC Genomics. 2014 Aug 28;15(1):732. doi: 10.1186/1471-2164-15-732. BMC Genomics. 2014. PMID: 25167919 Free PMC article.
Early-onset endocrine disruptor-induced prostatitis in the rat.
Cowin PA, Foster P, Pedersen J, Hedwards S, McPherson SJ, Risbridger GP. Cowin PA, et al. Environ Health Perspect. 2008 Jul;116(7):923-9. doi: 10.1289/ehp.11239. Environ Health Perspect. 2008. PMID: 18629315 Free PMC article.
Formation of human prostate tissue from embryonic stem cells.
Taylor RA, Cowin PA, Cunha GR, Pera M, Trounson AO, Pedersen J, Risbridger GP. Taylor RA, et al. Among authors: cowin pa. Nat Methods. 2006 Mar;3(3):179-81. doi: 10.1038/nmeth855. Nat Methods. 2006. PMID: 16489334
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin.
Cowin PA, George J, Fereday S, Loehrer E, Van Loo P, Cullinane C, Etemadmoghadam D, Ftouni S, Galletta L, Anglesio MS, Hendley J, Bowes L, Sheppard KE, Christie EL, Pearson RB, Harnett PR, Heinzelmann-Schwarz V, Friedlander M, McNally O, Quinn M, Campbell P, deFazio A, Bowtell DD; Australian Ovarian Cancer Study. Cowin PA, et al. Cancer Res. 2012 Aug 15;72(16):4060-73. doi: 10.1158/0008-5472.CAN-12-0203. Cancer Res. 2012. PMID: 22896685 Free article.
IL6-STAT3-HIF signaling and therapeutic response to the angiogenesis inhibitor sunitinib in ovarian clear cell cancer.
Anglesio MS, George J, Kulbe H, Friedlander M, Rischin D, Lemech C, Power J, Coward J, Cowin PA, House CM, Chakravarty P, Gorringe KL, Campbell IG; Australian Ovarian Cancer Study Group, Okamoto A, Birrer MJ, Huntsman DG, de Fazio A, Kalloger SE, Balkwill F, Gilks CB, Bowtell DD. Anglesio MS, et al. Among authors: cowin pa. Clin Cancer Res. 2011 Apr 15;17(8):2538-48. doi: 10.1158/1078-0432.CCR-10-3314. Epub 2011 Feb 22. Clin Cancer Res. 2011. PMID: 21343371 Free article. Clinical Trial.
Deregulation of MYCN, LIN28B and LET7 in a molecular subtype of aggressive high-grade serous ovarian cancers.
Helland Å, Anglesio MS, George J, Cowin PA, Johnstone CN, House CM, Sheppard KE, Etemadmoghadam D, Melnyk N, Rustgi AK, Phillips WA, Johnsen H, Holm R, Kristensen GB, Birrer MJ; Australian Ovarian Cancer Study Group, Pearson RB, Børresen-Dale AL, Huntsman DG, deFazio A, Creighton CJ, Smyth GK, Bowtell DD. Helland Å, et al. Among authors: cowin pa. PLoS One. 2011 Apr 13;6(4):e18064. doi: 10.1371/journal.pone.0018064. PLoS One. 2011. PMID: 21533284 Free PMC article.